Podcasts about child neurology

Casar com o primo faz mal? Separe trinta minutinhos do seu dia e descubra, com Mila Massuda, como a endogamia pode afetar a saúde de pessoas, plantas, animais e até de espécies inteiras. Do queixo dos Habsburgos aos filhos de Darwin, passando pelas ervilhas de Mendel, esse episódio mostra por que cruzar com quem é aparentado pode não ser uma boa ideia e o que a genética tem a ver com tudo isso.Apresentação: Mila Massuda (@milamassuda)Roteiro: Mila Massuda (@milamassuda) e Emilio Garcia (@emilioblablalogia)Revisão de Roteiro: Vee Almeida e Caio de Santis (@caiodesantis)Técnica de Gravação: Julianna Harsche (@juvisharsche)Editora: Lilian Correa (@_lilianleme)Mixagem e Masterização: Rafael de Falco (@rafel.falco) Produção: Prof. Vítor Soares (@profvitorsoares), Matheus Herédia (@Matheus_Heredia), BláBláLogia (@blablalogia), Caio de Santis (@caiodesantis) e Biologia em Meia Hora (@biologiaemmeiahora)Gravado e editado nos estúdios TocaCast, do grupo Tocalivros (@tocalivros)REFERÊNCIASBITTLES, A. H. The bases of Western attitudes to consanguineous marriage. Developmental Medicine & Child Neurology, v. 45, p. 135–138, 2003.BITTLES, A. H.; BLACK, M. L. Consanguinity, human evolution, and complex diseases. Proceedings of the National Academy of Sciences, v. 107, supl. 1, p. 1779–1786, 2010. Disponível em: https://doi.org/10.1073/pnas.0906079106. Acesso em: 8 abr. 2025.BOUCHER, A. ‘But You Know There's a Cousin': Endogamous Marriage in Sensation Fiction. In: Science, Medicine, and Aristocratic Lineage in Victorian Popular Fiction. Cham: Palgrave Macmillan, 2023. Disponível em: https://doi.org/10.1007/978-3-031-41141-0_4. Acesso em: 8 abr. 2025.CHARLESWORTH, D.; WILLIS, J. H. The genetics of inbreeding depression. Nature Reviews Genetics, v. 10, n. 11, p. 783–796, 2009. Disponível em: https://doi.org/10.1038/nrg2664. Acesso em: 8 abr. 2025.DARWIN, C. On the Various Contrivances by Which British and Foreign Orchids Are Fertilized by Insects, and on the Good Effects of Intercrossing. London: John Murray, 1862. p. 359–360.DARWIN, C. The Effects of Cross and Self-Fertilization in the Vegetable Kingdom. London: John Murray, 1876. p. 460–461.DARWIN, G. H. Marriages between first cousins in England and Wales and their effects. Journal of the Statistical Society, v. 38, p. 153–184, 1875.KELLER, L. F.; WALLER, D. M. Inbreeding effects in wild populations. Trends in Ecology & Evolution, v. 17, n. 5, p. 230–241, 2002. Disponível em: https://doi.org/10.1016/S0169-5347(02)02489-8. Acesso em: 8 abr. 2025.OTTENHEIMER, M. Forbidden Relatives: The American Myth of Cousin Marriage. Urbana: University of Illinois Press, 1996.

In the first episode of TSC Now in 2025, host Dan Klein tackles the challenging topic of what happens when a clinical trial fails and how failed clinical trials inform future research in tuberous sclerosis complex (TSC). Dan interviews Mary Kay Koenig, MD, Professor of Child Neurology and Associate Vice Chair for Clinical Research at … Continue reading Episode 50: What happens when a clinical trial fails? →

For this episode, we discuss the roles and sensitivity of mitochondria with Dr. Richard Frye, MD, PhD. Dr. Frye received an MD and a PhD in Physiology and Biophysics from Georgetown University. He is board certified in Pediatrics, Neurology with special competence in Child Neurology, and as a Certified Principal Investigator. In addition, he has a Masters in Biomedical Sciences and Biostatistics from Drexel University. Dr. Frye has over 300 publications in leading journals and book chapters.Dr. Frye shares many figures during the conversation so the listener can follow along.Dr. Richard Frye https://drfryemdphd.comRossingnol Medical Center Facebook https://www.facebook.com/RossignolMedicalCenterNeurological Health Foundation https://neurologicalhealth.orgHealthy Child Guide https://neurologicalhealth.org/the-guide-5/Daylight Computer Company https://daylightcomputer.com?sca_ref=8231379.3e0N25Wg3wuse "autism" in the discount code for $25 coupon.This is the future of tech.Chroma Light Therapy https://getchroma.co/?ref=autismuse "autism" for a 10% discount,0:00 Dr. Richard Frye0:58 Daylight Computer Company5:17 Chroma Light Devices8:27 History of Leucovorin; low risk, high reward; Folate Receptor Alpha (FRa)10:25 Blood Brain Barrier; Folate; CSF (cerebral spinal fluid)14:04 DNA, RNA; MTHFR (Methylenetetrahydrofolate reductase)17:34 Cerebral Folate deficiency; BH4, Placenta & Womb23:35 Folate deficiency & Autism26:21 Clinical Studies & Data29:28 Folate & Mitochondria; Cerebral Folate Antibodies; White Matter Findings (!)34:45 Cerebral Folate deficiency & Ranges; Autistic Phenotypes: Language, Communication, & Behaviors40:45 Language & Communication; Self-Injurious Behaviors; Hyperactivity, Agitation; Treatment duration42:53 Folate Autoantibodies & Maternal Health & Markers45:30 Studies & Behavioral outcomes; inflammation & thyroid findings46:58 Neural development; Language connections, white matter tracts & distal connections48:53 Leucovorin for different severity/levels of Autism; Spinal Bifida51:08 Preparing for pregnancy53:50 Transgenerational aspects of Folate Autoantibodies Research; Prenatal Care & Awareness59:32 Guidance & SupportX: https://x.com/rps47586Hopp: https://www.hopp.bio/fromthespectrumYT: https://www.youtube.com/channel/UCGxEzLKXkjppo3nqmpXpzuAemail: info.fromthespectrum@gmail.com

Most people believe that strokes only affect adults, but children can experience them too. Although rare, strokes in kids can lead to catastrophic outcomes if not treated properly. Seizure or migraines are often misdiagnosed in this population, making it crucial to have proper protocols in place. While many never think of stroke as something that can impact kids, it's still in the top 10 causes of death in children.  To understand the scope of pediatric stroke and the strides being made to prevent and treat it, we are joined by two experts. Timothy Bernard, MD, is the Director of Education for the section of Child Neurology, and the Director of the Childhood Stroke Program here at Children's Hospital Colorado. He is also a Professor of Pediatrics and Neurology at the University of Colorado School of Medicine. Ethan Rosenberg, MD, is the Director of Inpatient Childhood Stroke and Neurocritical Care. He is also an Assistant Professor of Pediatrics and Neurology.  Some highlights from this episode include:  Understanding diagnosis in this population  What causes stroke in kids  Why there are delays in recognizing stroke symptoms in younger children  The role of the primary care provider with stroke protocol   For more information on Children's Colorado, visit: childrenscolorado.org. 

In today's episode, I sit down with Dr. Anjalee Galion, a pediatric neurologist and sleep medicine specialist, who shares her inspiring educational journey and her insights about the importance of sleep for teenagers. We talk about the crucial role sleep plays in adolescent health, and how consistent sleep habits and exercise can improve overall well-being. Don't miss these valuable insights to help your child thrive!Bio:Dr. Anjalee Galion is a leader in the field of pediatric neurology and sleep medicine. She practices at the Children's Hospital of Orange County now under the Rady Children's Health System in Southern California.  For CHOC Children's, Dr. Galion serves in several leadership roles including the inaugural Chief Wellness Officer for the healthcare system and as of 2025 she assumed the role as President of the Medical Staff. Dr. Galion has a commitment to fostering the next generation, winning multiple teaching awards at UCSF and CHOC, having previously served as a Program Director for the Child Neurology training program, and founding the Pediatric Subspecialty Faculty's Junior Faculty Leadership Council. Dr. Galion currently chairs the Council on Medical Services (CMS) for the California Medical Association and holds leadership positions representing California for the American Medical Association. Follow Dr. Anjalee on LinkedIn: https://www.linkedin.com/in/anjalee-galion-md-mba-173154224/Sign up for a chance to be featured on our podcast and get personalized insights!Students: https://forms.gle/cRyBSFP9tSEJnsVN6Parents and other Adults: https://forms.gle/v6Nppxix6HPKrRfdAAccess free resources and learn more about Sheila and her team at Signet Education at signeteducation.com or on LinkedIn at https://www.linkedin.com/in/sheilaakbar/.

Welcome to Episode 245 of Autism Parenting Secrets. In this episode of Autism Parenting Secrets, we're joined by Dr. Richard Frye, a renowned child neurologist specializing in neurodevelopmental disorders, to explore the critical medical insights that can help children with autism thrive. Dr. Frye shares his expertise on mitochondrial dysfunction, immune system dysregulation, and other underlying medical issues affecting autism. We discuss the importance of evidence-based treatments, foundational aspects like sleep and gut health, and the significance of a tailored approach to each child's unique needs. Join us as we delve into the strategies and emerging interventions that offer the most promise for helping children with autism live their best lives.The secret this week is... EVIDENCE-BASED Treatments FIRSTYou'll Discover:Two Connected Challenges to Tackle Early in the Journey (4:15)Signs of Poor Gut Health (11:29)Three Key Issues You Can Measure and Treat (19:58)Why Mitochondria Matter So Much (22:49)The Importance of Folate Metabolism (25:35)Why Less Is MORE (34:43)About Our Guest:Dr Frye is a Child Neurologist with expertise in neurodevelopmental and neurometabolic disorders. He received an MD and PhD in Physiology and Biophysics from Georgetown University.  He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children's Hospital Boston, and Fellowship in Psychology at Boston University.  He also received a Master's in Biomedical Science and Biostatistics from Drexel University. He holds board certifications in Pediatrics and Neurology with Special Competence in Child Neurology.  He has authored over 300 publications and book chapters and serves on several editorial boards.Dr. Frye is a national leader in autism spectrum disorder (ASD) research. He is President and Chief Scientific Officer of the Autism Discovery and Treatment Foundation, Chief Medical Officer of the Neurological Health Foundation, Director of Research and Neurologist at the Rossignol Medical Center, and Principal Investigator at the Southwest Autism Research and Resource Center.He has led several clinical studies on children with ASD, including studies focusing on defining the clinical, behavioral, cognitive, genetic, and metabolic characteristics of children with ASD and mitochondrial disease and several clinical trials demonstrating the efficacy of safe and novel treatments that target underlying physiological abnormalities in children with ASD, including studies on leucovorin, cobalamin and tetrahydrobiopterin and has an ongoing multicenter controlled clinical trial on leucovorin, neuroimmune modulators and photobiomodulation.https://drfryemdphd.com/References in The Episode:Medical Academy of Pediatrics & Special Needs MAPSAdditional Resources:Unlock the power of personalized 1-on-1 support, visit allinparentcoaching.com/intensiveTake The Quiz: What's YOUR Top Autism Parenting Blindspot?To learn more about Cass & Len, visit us at www.autismparentingsecrets.comBe sure to follow Cass & Len on InstagramIf you enjoyed this episode, share it with your friends.

In the third part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the best strategies to enhance EEG education in child neurology and neurodevelopmental disability programs. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112  

In the second part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the current state of EEG education in child neurology and neurodevelopmental disability programs, focusing on EEG rotation characteristics and resident evaluations. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112 

In the first part of this three-part series, Dr. Irfan Sheikh and Dr. Roohi Katyal discuss the significance of this publication and the objectives their team aimed to achieve with the study. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200112

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we cover the recent approval of Avadel's sodium oxybate formulation (Lumryz) as a treatment for pediatric patients with narcolepsy aged 7 years and older. The new indication expands on its previous one, granted in May 2023, which included the the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. It's initial approval was based on data from the phase 3 REST-ON trial (NCT02720744), a large-scale study in which the therapy met all 3 of its primary end points of change from baseline in mean sleep latency on the Maintenance of Wakefulness test, Clinical Global Impression Improvement, and weekly cataplexy attacks. Following its new indication, NeurologyLive sat down with Anne Marie Morse, DO, FAASM, a pediatric sleep disorders expert, to discuss the significance of the new approval. Morse, director of Child Neurology and Pediatric Sleep Medicine at Geisinger Janet Weis Children's Hospital as well as the program director for Child Neurology Residency Program, provided commentary on the clinical considerations behind this once-nightly formulation of sodium oxybate, and how it should be used going forward. For more of NeurologyLive's coverage of sodium oxybate's (Lumryz) expanded indication, head here: FDA Approves Avadel's Sodium Oxybate for Cataplexy or Excessive Daytime Sleepiness in Pedatric Narcolepsy Episode Breakdown: 2:10 – Immediate reaction and significance  4:10 – Considerations and caution with prescribing sodium oxybate 8:20 – Closing remarks and the need to utilize highly effective treatments for narcolepsy Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746

In this episode, we dive into the fascinating intersection of artificial intelligence and pediatric neurology. Our guest shares how they became interested in AI's role in healthcare and discusses how AI is being utilized to enhance diagnostic accuracy, especially in neurodevelopmental pediatrics. We explore how these advancements are improving access to care in resource-limited settings and the impact of early diagnosis on long-term outcomes for conditions like autism. Join us as we uncover the latest technological innovations transforming pediatric healthcare, the potential of AI to personalize treatment plans for children, and the concerns surrounding the widespread use of AI in medicine. Dr. Sharief Taraman, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine. Dr. Taraman was the former Division Chief of Pediatric Neurology at Children's Health of Orange County and University of California-Irvine. He remains an active member of the medical staff and the Sharon Disney Lund Medical Intelligence, Information, Investigation, & Innovation Institute at CHOC. He is a Health Sciences Associate Clinical Professor at UC Irvine School of Medicine in the Department of Pediatrics and Affiliate Professor at Chapman University, Dale E. and Sarah Ann Fowler School of Engineering. Dr. Taraman is active in the community as the past president of the American Academy of Pediatrics (AAP) Orange County Chapter, board member of AAP-California, and committee member for the development of the AAP National CHILD health registry. He also serves on the Irvine Unified School District Medical Advisory Board, volunteers for the Capistrano Unified School District and with Girl Scouts of Orange County. Recognized globally as an innovator and specifically an advocate in the field of pediatrics, Dr. Taraman has been involved with the development of three FDA designated breakthrough devices, awardee of the prestigious National Capital Consortium for Pediatric Device Innovation grant, and is an advisor to Board of Directors for the International Society for Pediatric Innovation. He is the Chief Executive Officer at Cognoa and formerly served as the Chief Medical Officer leading the clinical trials that led to the FDA authorization of Cognoa's lead product, Canvas Dx, the first and only FDA authorized diagnostic device for autism for children 18-72 months old with concern for developmental delay. Dr. Taraman graduated Magna Cum Laude from the University of Michigan having majored in Biochemistry. He completed his medical education at Wayne State University School of Medicine and went on to complete residency and fellowship training in Pediatrics and Pediatric Neurology at the Detroit Medical Center and Children's Hospital of Michigan. He continued professional development through the University of California, Irvine - The Paul Merage School of Business with certifications in Leadership for Healthcare Transformation & Physician Leadership. https://cognoa.com/ _________________________________________________ Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter!www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

Dr. Dara Albert talks with Dr. Jaclyn M. Martindale about the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

In this episode, we dive into the fascinating intersection of artificial intelligence and pediatric neurology. Dr. Taraman shares how he became interested in AI's role in healthcare and discusses how AI is being utilized to enhance diagnostic accuracy, especially in neurodevelopmental pediatrics. We explore how these advancements are improving access to care in resource-limited settings and the impact of early diagnosis on long-term outcomes for conditions like autism.Dr. Sharief Taraman, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine.Dr. Taraman was the former Division Chief of Pediatric Neurology at Children's Health of Orange County and University of California-Irvine. He remains an active member of the medical staff and the Sharon Disney Lund Medical Intelligence, Information, Investigation, & Innovation Institute at CHOC.He is a Health Sciences Associate Clinical Professor at UC Irvine School of Medicine in the Department of Pediatrics and Affiliate Professor at Chapman University, Dale E. and Sarah Ann Fowler School of Engineering.Dr. Taraman is active in the community as the past president of the American Academy of Pediatrics (AAP) Orange County Chapter, board member of AAP-California, and committee member for the development of the AAP National CHILD health registry. He also serves on the Irvine Unified School District Medical Advisory Board, volunteers for the Capistrano Unified School District and with Girl Scouts of Orange County.Recognized globally as an innovator and specifically an advocate in the field of pediatrics, Dr. Taraman has been involved with the development of three FDA designated breakthrough devices, awardee of the prestigious National Capital Consortium for Pediatric Device Innovation grant, and is an advisor to Board of Directors for the International Society for Pediatric Innovation.He is the Chief Executive Officer at Cognoa and formerly served as the Chief Medical Officer leading the clinical trials that led to the FDA authorization of Cognoa's lead product, Canvas Dx, the first and only FDA authorized diagnostic device for autism for children 18-72 months old with concern for developmental delay.Dr. Taraman graduated Magna Cum Laude from the University of Michigan having majored in Biochemistry. He completed his medical education at Wayne State University School of Medicine and went on to complete residency and fellowship training in Pediatrics and Pediatric Neurology at the Detroit Medical Center and Children's Hospital of Michigan. He continued professional development through the University of California, Irvine - The Paul Merage School of Business with certifications in Leadership for Healthcare Transformation & Physician Leadership.https://cognoa.com/This week's episode is sponsored by Toveedo! The Jewish videos your kids love, all in one happy place. Use code JOWMA10 for $10 off at ⁠⁠⁠https://toveedo.com/⁠⁠⁠! _________________________________________________​Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org​Become a JOWMA Member! www.jowma.org ​Follow us on Instagram! www.instagram.com/JOWMA_org ​Follow us on Twitter!www.twitter.com/JOWMA_med ​Follow us on Facebook! https://www.facebook.com/JOWMAorg​Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

For this episode, we discuss the roles and sensitivity of mitochondria with Dr. Richard Frye, MD, PhD. Dr. Frye received an MD and a PhD in Physiology and Biophysics from Georgetown University. He is board certified in Pediatrics, Neurology with special competence in Child Neurology, and as a Certified Principal Investigator. In addition, he has a Masters in Biomedical Sciences and Biostatistics from Drexel University. Dr. Frye has over 300 publications in leading journals and book chapters.He currently sees patients as a Neurologists and Director of Research at Rossingnol Medical Center and at Neurodevelopmental Precision Medicine. In 2022, Dr. Frye co-founded the Autism Discovery and Treatment Foundation where they are dedicated to discover biomarkers, metabolic endophenotypes, and treatments for neurodevelopemental disorders.Dr. Frye shares many figures during the conversation so the listener can follow along.Dr, Richard Frye https://drfryemdphd.comCV https://wparticles.seek2understand.org/wp-content/uploads/2023/02/DrFryeCVJan2023.pdfRossingnol Medical Center Facebook https://www.facebook.com/RossignolMedicalCenterNeurobiology of Disease 2024 paper https://www.sciencedirect.com/science/article/pii/S0969996124001190?via%3DihubAutism and GI, and exploring how changes in Light have major implications (Apple) https://podcasts.apple.com/us/podcast/from-the-spectrum-finding-superpowers-with-autism/id1737499562?i=1000664349495 0:00 Dr. Richard Frye6:13 Intro into mitochondria & energy production, various disease & dysfunction11:16 Mitochondrial DNA, sensitivity, and the roles with epigenetics16:16 Biomarkers of mitochondrial dysfunction, delicate delivery (space and time) into the electron transport chain20:58 Cytochrome C Oxidase (complex IV); Carnitine, Fat, and Creatine26:57 Molecules connected to aging & cellular respiration, environemental signals implicating mitochondria30:26 Terrible Trio: oxidative stress, mitochondria dysfunction, immune/inflammation, DAMPS & inflammation34:29 Environmental risks for the Embryo, overreactivity of mitochondria (200%) and physiological insults and regression42:50 Tryptophan (aromatic amino acid), NAD, and Gastrointestinal biosynthesis45:52 Light as an environmental change factoring into the Autistic Phenotype, Infant Tree and Adult Tree examples; Vitamin D (skin & brain are connected through Neuroectoderm)54:54 Future Research59:58 Wrap up, Reviews/RatingsX: https://twitter.com/rps47586Hopp: https://www.hopp.bio/fromthespectrumemail: info.fromthespectrum@gmail.com

Child Neurology advancements at UK HealthCare, with specific focus on work at Kentucky Neuroscience Institute to address Spinal Muscular Atrophy and Duchenne's Muscular Distrophy

Labels op mensen plakken is tegenwoordig vrij normaal. Sommige mensen vinden dat erg fijn. Anderen niet. We vinden er eigenlijk allemaal wel wat van. In deze aflevering onderzoeken Thijs en Lennard of labels nuttig zijn en waar ze juist problematisch voor zijn. Je leert hoe psychologische labels worden verzonnen, hoe je ze dan uiteindelijk opgespeld krijgt en wat daar behulpzaam en minder behulpzaam aan is. Daarnaast staan ze kort stil bij het overlijden van grote held in de psychologie: Daniel Kahneman. Adverteren in deze podcast? Mail naar podcasts@astrolads.com Bronnen en ander lees- en luister- en kijkvoer: - Info over de DMS-5: https://www.nvvp.net/website/onderwerpen/detail/dsm-5 die je trouwens ook hier kunt vinden, mocht je geïnteresseerd zijn: https://dsm-5.nl/ - Een interessant interview van Rijksuniversiteit Groningen over labels: https://www.rug.nl/gmw/research/verslag-publieksacademie/zin-en-onzin-psychische-labels/?lang=en - Of in Psychology Today: https://www.psychologytoday.com/intl/blog/escaping-our-mental-traps/202307/rethinking-mental-health-challenging-the-dangers-of-labels - Een interessante TED-x talk van Rwenshaun Miller die het label bipolaire stoornis heeft. Hij vertelt hoe hij positief omgaat met dit label en andere labels die hij heeft. https://www.youtube.com/watch?v=KjQ7bYHizSU - Filmpje van een therapeute die vertelt wat het gevaar is van labels voor de therapeuten zelf (en daarmee voor de cliënt). Denkfouten sluipen er alsnog in bij therapeuten als ze uitgaan bij een cliënt van een label: https://www.youtube.com/watch?v=BjiXQNcqZhE Nerd-literatuur: - Werkhoven, S., Anderson, J. H., & Robeyns, I. A. (2022). Who benefits from diagnostic labels for developmental disorders?. Developmental Medicine & Child Neurology, 64(8), 944-949. - Sweet, P. L., & Decoteau, C. L. (2018). Contesting normal: The DSM-5 and psychiatric subjectivation. BioSocieties, 13, 103-122. - Thyer, B. A. (2015). The DSM-5 definition of mental disorder: Critique and alternatives. Critical thinking in clinical assessment and diagnosis, 45-68. - Farrington, D. P., Osborn, S. G., & West, D. J. (1978). The persistence of labelling effects. Brit. J. Criminology, 18, 277. - Pohl, R. F. (2012). Effects of labelling. In Cognitive illusions (pp. 339-356). Psychology Press.

Drs. Jeff Ratliff, Dara V. F. Albert, and Afsaneh Talai discuss understanding the gaps in resident education on psychogenic nonepileptic seizures. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200111  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jeff Ratliff talks with Drs. Dara V. F. Albert and Afsaneh Talai about understanding the gaps in resident education on psychogenic nonepileptic seizures. Read the related article in Neurology: Education.  Disclosures can be found at Neurology.org.

Welcome back to the Neurophilia Podcast! Today we are joined by the legendary duo Dr. Zach London and Dr. Ali Christy to talk more about game-based learning in the field of neurology including their games Endowed Chairs and Neurdle.  Listen along to learn more about the origins of the London-Christy duo, the process of game development, and the future projects of London-Christy. This podcast was a blast to record and we hope you enjoy listening to the full episode! Dr. Zach London is a neuromuscular neurologist and adult neurology program director at the University of Michigan. He is the founder of NeurdGames and the Hard Taco Project. He is passionate about education beyond the classroom and has dedicated his professional career to creating playful and accessible ways to teach clinical neurology. For his passion and efforts, Dr. London was awarded the AAN's most prestigious teaching award, the A.B. Baker Award for Lifetime Achievement in Neurologic Education in 2023.Dr. Ali Christy is a pediatric neurologist in Portland, Oregon with a focus on neuroimmunology and a love of the history of medicine, particularly the stories of early women physicians. She is the deputy editor of the Journal of Child Neurology, and she makes podcasts for these journals as well. Follow Dr.  Zach London on Twitter @Zach_LondonFollow Dr.  Ali Christy on Twitter @OligoclonalBand Follow Dr.  Nupur Goel on Twitter @mdgoelsFollow Dr.  Blake Buletko on Twitter @blakebuletkoFollow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPodEdwards, S. L., Gantwerker, E., Cosimini, M., Christy, A. L., Kaur, A. W., Helms, A. K., Stiver, M. L., & London, Z. (2023). Game-based learning in Neuroscience. Neurology Education, 2(4). https://doi.org/10.1212/ne9.0000000000200103 https://www.neurdle.com/https://www.neurdgames.com/Support the show

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: What will it take to shatter systemic barriers obstructing timely and equitable pediatric care? According to our next guest, Dr. Sharief Taraman, Chief Executive Officer of Cognoa, it starts with responsible AI adoption designed to uplift all patients. As creators of the first and only FDA-authorized diagnostic for autism, Cognoa continues pioneering digital health solutions upholding diversity, cost savings, and care team empowerment. While together, Dr. Taraman passionately shares Cognoa's mission of democratizing quality care, how their autism diagnostic is dissolving geographic and financial obstacles through telehealth accessibility, and why he urges investors to back ventures tackling pediatric device gaps spanning ADHD, anxiety, speech impediments, and more. Join us as Dr. Taraman shares why he and his team at Cognoa are so dedicated to unlocking equitable pediatric care. Lets go! Episode Highlights:How Cognoa launched 1st ever FDA-authorized diagnostic test for autismExtracting digital biomarkers from parental questionnaires and child observation videosReducing disparities by maintaining high accuracy across patient demographicsAuto-generating necessary evaluation documentation to alleviate administrative burdensCognoa's pursuit to earn breakthrough designation for condensed 6-week autism behavioral therapyAbout our Guest: Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine. He formerly served as the Division Chief of Pediatric Neurology for the CHOC Children's Specialists Pediatric Subspecialty Faculty and is a Clinical Associate Professor of Pediatrics at UC Irvine School of Medicine. Dr. Taraman is the Chief Executive Officer of Cognoa, a leading early childhood development and pediatric behavioral health company, creator of the first and only FDAauthorized diagnostic for autism and early, rapid developmental health evaluation, designed to increase childhood access to life-changing early intervention and treatment of behavioral health conditions. Links Supporting This Episode:Cognoa Website: CLICK HEREDr. Sharief Taraman LinkedIn page: CLICK HERECognia LinkedIn page: CLICK HERE Mike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Jennifer Bain, MD, PhD, is an assistant professor of neurology and pediatrics at Columbia University Medical Center.  Dr. Bain completed both an M.D. and PhD. as well as general pediatrics residency at Rutgers – New Jersey Medical School in New Jersey.  She then trained in Child Neurology at New York Presbyterian – Columbia University Medical Center in New York City and is a board-certified neurologist with special certification in Child Neurology seeing both inpatient and outpatient pediatric neurology patients. Her clinic focuses on diagnosis and management of autism, cerebral palsy and neurodevelopmental disorders in addition to genetic disorders associated with such conditions. Her early research career focused on spinal cord and brain development after injuries such as spinal cord injury and perinatal hypoxic ischemic encephalopathy.  During her residency training, her clinical research focused on studying autonomic dysfunction in children with autism spectrum disorders and neurological complications during extracorporeal membrane oxygenation. She currently works as a physician scientist at Columbia University specializing in general pediatric neurology with expertise in development, behavioral neurology, autism and cerebral palsy.  Her clinical research has focused on studying the genetics of neurodevelopmental disorders including autism and cerebral palsy. The genes she has worked closely on include HNRNPH2 and related disorders, GRIN disorders, KIF1A. She is interested in understanding clinically meaningful measures in families affected by neurodevelopmental disorders and measuring longitudinal trajectories in such disorders. She has been working closely with several patient advocacy groups, researchers, and Simons Searchlight to continuously move forward in the understanding of the developing and aging brain. JOWMA Podcast | Learn The Signs, Act Early: Dr. Lisa Shulman on the Early Identification and Treatment of Autism https://anchor.fm/jowma/episodes/Learn-The-Signs--Act-Early-Dr--Lisa-Shulman-on-the-Early-Identification-and-Treatment-of-Autism-e22noo5 JOWMA Podcast | All Brains Belong with Dr. Mel Houser, MD https://anchor.fm/jowma/episodes/All-Brains-Belong-with-Dr--Mel-Houser--MD-e1t1rjn JOWMA Podcast | Uniquely Human with Dr. Barry Prizant, PhD, CCC-SLP https://anchor.fm/jowma/episodes/Uniquely-Human-with-Dr--Barry-Prizant--PhD--CCC-SLP-e1ogbg2 JOWMA Podcast | It Takes A Village- Advocating for Inclusion with Esti Schiffmiller https://anchor.fm/jowma/episodes/It-Takes-A-Village--Advocating-for-Inclusion-with-Esti-Schiffmiller-e1klr32 JOWMA Podcast | On The Spectrum: All About Autism With Dr. Devorah Segal https://anchor.fm/jowma/episodes/On-The-Spectrum-All-About-Autism-With-Dr--Devorah-Segal-e1eqv4u JOWMA Podcast | "If you've met one individual with autism, you've met one individual with autism." The Journey of Dr. Stephen Shore, Autistic Professor of Special Education https://anchor.fm/jowma/episodes/If-youve-met-one-individual-with-autism--youve-met-one-individual-with-autism--The-Journey-of-Dr--Stephen-Shore--Autistic-Professor-of-Special-Education-e1eqv4k_______________________________________________________ ⁠⁠⁠Become a JOWMA Member!⁠⁠⁠ www.jowma.org  ⁠⁠⁠Follow us on Instagram!⁠⁠⁠ www.instagram.com/JOWMA_org  ⁠⁠⁠Follow us on Twitter!⁠⁠⁠ www.twitter.com/JOWMA_med  ⁠⁠⁠Follow us on Facebook! ⁠⁠⁠https://www.facebook.com/JOWMAorg/ ⁠⁠⁠Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! ⁠⁠⁠https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

Chanel grew up in Detroit and adopted a love for writing at an early age. As young as 8 years old she participated in various writing and oratorical contests to hone her skills. As Chanel advanced through school she continued to participate in writing contests, published poems and participated in creative writing programs.Chanel graduated from the University of Michigan-Dearborn with a double major in Psychology and Criminal Justice and a minor in Communications. She had the dream of pursuing a law career but life took a different turn. Instead, she worked in the social services field, working with underprivileged youth in group homes and independent living programs. Chanel eventually came to the realization that she wanted to reach children much earlier in life. The goal being, to help alleviate some of the issues and problems that plagued the children within, her then, current position. It was at this time Chanel started working at the Georgia Institute of Technology – Child Study Lab, as a research Assistant.In her position at Georgia Tech, Chanel assisted with research to help in the early detection of Autism and other developmental delays. While working as a research assistant, she was co-author on scholarly articles that were published in journals such as: The Journal of Developmental Medicine and Child Neurology, Nature Communications and the Journal of Autism and Developmental Disorders.At Georgia Tech Chanel also became a co-instructor for the Universities freshman seminar course, for incoming first year students. During this time, she started to pursue her Masters in Public Policy at the Andrew Young School of Policy Studies, at Georgia State.Shortly after starting schooling for her Masters Degree, Chanel got married to her husband, Justin Miller. After getting married and having children, her career goals shifted. She put her masters degree on hold and left academia to become a stay at home mom. Once her children grew, she started the blog, Them 3 and Me, where she wrote about life as a stay at home mom who also homeschools. The blog led Chanel to start self publishing her own literary works, the first being, Kid De Cuisine: Hadasah's Breakfast Delights. Some of her other works include: 10 rockets Blast into Space and From Sand to Sea and Back Again.Connect with Chanel below:https://them3andme.comhttps://instagram.com/them3andme?utm_source=qr&igshid=NGExMmI2YTkyZg%3D%3Dhttps://www.facebook.com/profile.php?id=100090411283767&mibextid=ZbWKwLSupport the showFollow Moms Who Create:Instagram - https://www.instagram.com/momswhocreatepodcast/Facebook - https://www.facebook.com/momswhocreatepodcastMonthly Meeting Book Club - https://www.facebook.com/groups/momswhocreatebookclubWebsite - https://www.momswhocreate.com/

Wie lange darf gedaddelt werden, ohne dass es schon Abhängigkeit ist? Es hängt ganz vom Alter und qualitativen Kriterien ab, ob die „Dosis“ steigt und das Leben davon beeinträchtigt wird. Dr. Frank W. Paulus, leitender Psychologe der Klinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie in Homburg / Saar gibt im Gespräch mit Dr. Axel Enninger zu bedenken, dass Sätze wie: „Lass das doch, das ist doch Quatsch!“ kaum weiterhelfen. Eher unterstützt das Umfeld durch Mediennutzungsregeln, Vorbildfunktion und die „Minimal-Intervention" Interesse zu zeigen. Im Hinterkopf behalten sollten Pädiater, dass eine weitere psychische Störung hinter exzessivem Gaming und Messaging stecken kann. Hilfreiche Informationen: Informationen für Fachpersonal und Eltern: Elternratgeber Internet der Bundespsychotherapeutenkammer: https://www.bptk.de/wp-content/uploads/2020/10/bptk-elternratgeber-internet.pdf EU-Initiative klicksafe https://www.klicksafe.de/ ADUPS – Ambulanz Digitalisierung Und Psychische Störungen der Kinder- und Jugendpsychiatrie am Universitätsklinikum des Saarlandes: https://www.uniklinikum-saarland.de/de/einrichtungen/kliniken_institute/kinder_und_jugendmedizin/kinder_und_jugendpsychiatrie/ambulanz_und_spezialsprechstunden/ambulanz_digitalisierung_und_psychische_stoerungen_adups Literatur Gaming: Paulus, F.W. (2022). Computerspielabhängigkeit bei Kindern und Jugendlichen. Consilium Themenheft. InfectoPharm Arzneimittel und Consilium GmbH, Heppenheim. www.infectopharm.com. ISSN 2365-7618. Paulus F.W. & Hessel, S. (2019). Digitale Spielzeuge, Bildschirme und Kindergesundheit in der zweiten Moderne. Kinderärztliche Praxis, 90(4), 248–255. Paulus, F.W., Lion, T. & Möhler, E. (2020). Computerspielabhängigkeit als Herausforderung: Der Psychotherapeut oder Arzt als Avatar des Patienten? pädiatrische praxis, 95, 1–15. Paulus, F.W. (2018). Kinderwelten im Wandel: von der analogen zur digitalen Welt. Kinderärztliche Praxis, 89(2), 121–128. Mall, V. & Paulus, F.W. (2018). Elektronische Medien und frühe Kindheit. Pädiatrie up2date, 13(02), 119-134, doi: 10.1055/s-0043-115286. Paulus, F. W. et al. (2018). Internet Gaming Disorder in children and adolescents: a systematic review. Developmental Medicine & Child Neurology. 60 (7), 645–659. doi: 10.1111/dmcn.13754. Weiterführende Literatur Cybergrooming und Cybermobbing: Paulus, F.W., Bédier, A., & Möhler, E. (2022). Tatort Internet: Cybergrooming als sexuelle Gewalt gegen Kinder und Jugendliche. pädiatrische praxis 98(1), 165–183. Paulus, F.W., Möhler, E., Ohmann, S. & Popow, C. (2020). Digitale Missachtung der Bedürfnisse und Rechte von Kindern und Jugendlichen: Cybermobbing. Kinder- und Jugendmedizin, 20, 238-246. Link zum Transkript: https://www.infectopharm.com/consilium/podcast/podcast-paediatrie/ Kontakte: Feedback zum Podcast? podcast@infectopharm.com Homepage zum Podcast: www.infectopharm.com/consilium/podcast/ Für Fachkreise: www.wissenwirkt.com und App „Wissen wirkt.“ für Android und iOS Homepage InfectoPharm: www.infectopharm.com Disclaimer: Der consilium – Pädiatrie-Podcast dient der neutralen medizinischen Information und Fortbildung für Ärzte. Für die Inhalte sind der Moderator und die Gäste verantwortlich, sie unterliegen dem wissenschaftlichen Wandel des Faches. Änderungen sind vorbehalten. Impressum: consilium ist eine Marke von InfectoPharm Arzneimittel und Consilium GmbH Von-Humboldt-Str. 1 64646 Heppenheim Tel.: 06252 957000 Fax: 06252 958844 E-Mail: kontakt@infectopharm.com Geschäftsführer: Philipp Zöller (Vors.), Michael Gilster, Dr. Markus Rudolph, Dr. Aldo Ammendola Registergericht: Darmstadt – HRB 24623 USt.-IdNr.: DE 172949642 Verantwortlich für den Inhalt: Dr. Markus Rudolph

The Child Neurology Foundation connects partners from all areas of the child neurology community so those navigating the journey of disease diagnosis, management, and care have ongoing support from those dedicated to treatments and cures. Their expanding network of patients and caregivers, volunteers and advocates, researchers and clinicians are committed to helping one another along the path that leads to the best quality of care — and the highest quality of life—for every child. Vision: "A world in which all children affected by neurologic disorders reach their full potential." Mission: "To serve as a collaborative center of education, resources, and support for children and their families living with neurologic conditions, and facilitate connection with medical professionals who care for them." Child Neurology Foundation is committed to helping children and their families living with a neurologic condition receive the best quality of care — and achieve their highest quality of life — by providing information, education, and one-on-one support when it's needed most. They offer one-on-one family support as well as a database of child neurological disorder information and resources, both accessible from the homepage of their website. Here's a link to their disorder directory - https://www.childneurologyfoundation.org/disorder-directory/ Connect to learn more: Website: https://www.childneurologyfoundation.org/ Contact Family Support: https://www.childneurologyfoundation.org/family-support/ Facebook: https://www.facebook.com/CNFoundation Twitter: @Child_Neurology Insta: @childneurologyfoundation As an Amazon Associate, I earn commissions from qualifying purchases. For more information about True North Disability Planning: Web: https://truenorthdisabilityplanning.com/ Podcast (ABC's of Disability Planning) - https://anchor.fm/abcs-disability-planning Waypoints - https://waypoints.substack.com/ Facebook: @TrueNorthDisabilityPlanning Twitter: @NeedsNavigator Resource store (free downloads too) - https://www.teacherspayteachers.com/Store/True-North-Disability-Planning --- Send in a voice message: https://podcasters.spotify.com/pod/show/abcs-disability-planning/message

Sara Schaefer discusses the art of saying "no"-- the when, the why, the how-- and how it contributes to wellness and career development, with Dr. Brenda Banwell, Chief of Child Neurology at the Children's Hospital of Philadelphia, and Dr. Zach London, Neurology Residency Program Director at the University of Michigan.

Dr. Devorah Segal was born in Baltimore and grew up in Brooklyn, NY. She graduated from Prospect Park Yeshiva and went to BJJ seminary, followed by Brooklyn College. She attended Mount Sinai Medical School, where she earned her medical degree and a PhD in neuroscience. She then completed a residency in child neurology at Rutgers New Jersey Medical School and a fellowship in pediatric neuro-oncology at NYU. Dr. Segal practiced general child neurology and neurogenetics at Weill Cornell for several years, where she was also the director of the Child Neurology residency training program. She then returned to NYU, where she practices pediatric neuro-oncology and is the Associate Director of the Comprehensive Neurofibromatosis Center at NYU and the director of the pediatric neuro-oncology fellowship. Dr. Segal is the principal investigator or co-investigator of several clinical trials looking for new treatments for nervous system tumors. She is also the site principal investigator of a clinical trial studying a treatment for metachromatic leukodystrophy. Dr. Segal lives in Passaic, NJ with her husband and 5 children, all of whom were born while she was in medical school.

Join us as Dr. Chris Barton, Assistant Professor in Child Neurology, shares his perspective on what he came to understand about learning science through Health Professions Education coursework at UofL, the book, Neuroteach, and how he is using that new knowledge to be an even better educator. He provides practical tips that you too can implement tomorrow as you supervise clinical learners. Don't miss this one. For questions or comments, please email us at FacFeed@Louisville.edu We would love to hear from you!

This episode covers the following topics:What is neurodiversityWhy it is  important for us as parents/doctors/educators to be familiar with this conceptThe difference between neurodiversity and disabilityAccepting neurodiversityWays to help address learning disabilitiesHow parents can support their neurodiverse childPositives of being neurodiverseHow structure/schedule/routine can help someone who is neurodiverseAbout Dr. Paige Kalika:Dr. Paige Kalika is an Assistant Professor of Clinical Neurology and Pediatrics.  She was born in Brooklyn, NY, and graduated from Cornell University in 2000.  She earned her medical degree at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (now Rowan-SOM) in 2004.  She completed her residency in Pediatrics at Jersey Shore University Medical Center in 2007 and her fellowship in Child Neurology at SUNY Downstate in Brooklyn, NY in 2010.  She is board certified in Neurology with special qualification in Child Neurology and is pursuing certification in headache medicine.Dr. Kalika joined the University of Miami Department of Neurology in 2011.  While she practices general child neurology, she has a particular interest in pediatric headache and migraine.  She is the director of the pediatric headache clinic at UHealth and at Jackson Memorial Hospital, where she does Botox treatments for chronic migraines.  Her research interests include treatment and prevention of acute migraine in pediatric populations.  She also has an interest in pediatric neurogenetics and sees patients in tandem with Genetics at UHealth at Weston.When not seeing patients, Dr. Kalika enjoys reading, baking, and spending time with her husband and two children.  She is slowly amassing an impressive collection of geeky dresses with pockets.  She is a fan of Florida winters, but not Florida summers.

In this episode, we speak with Dr. Gary Clark, President of the Texas Neurological Association, Chief of Child Neurology at Texas Children's Hospital, and Tenured Professor & Academic Chief at the Baylor College of Medicine in Houston. As a leader for one of the nation's largest training programs for pediatric neurologists, Dr. Clark is proud of his innovative program that has been consistently ranked top 3 in the country for almost a decade. We discuss the need for a shift in medicine towards treating the root causes of neurological diseases, what exactly goes into growing a specialty training program, and how we can solve the critical lack of child neurologists in America. Thanks for listening, and we hope you enjoyed the episode! ---- FOLLOW US:

Join us with Dr. Sumit Parikh, Director of the Cleveland Clinic Neurogenetics, Metabolic and Mitochondrial Disease program, and past president of the Mitochondrial Medicine Society. Learn more about the 2014-2015 publications based on collaborations and consensus surveys completed by the Mitochondrial Medicine Society. The landmark series of publications is the first to address existing standards of care and most common approaches to diagnosis, use of supplements and symptom management by leaders in mitochondrial medicine around the US. Key points: Mitochondrial medicine's complexity bring unique challenges to physicians The practice of Mitochondrial Medicine has varied from provider-to-provider Patients and families deserve uniformity in regards to diagnosis and treatment The MMS Consensus Project was conceived with this goal in mind About The Speaker Dr. Parikh is the Director of the Cleveland Clinic Neurogenetics, Metabolic & Mitochondrial disease program. His clinical and research interests include the genetic diagnosis and treatment of patients with mitochondrial cytopathies, inborn errors of metabolism, cognitive and developmental regression, autism, leukodystrophies and developmental delays. He is part of the North American Mitochondrial Disease Research Consortium (NAMDC) and the Primary Investigator for the Pearson Syndrome Natural History study. He is an invited lecturer at national meetings and hospitals. He completed his residency in pediatrics and fellowship in child neurology at the Children's Hospital of Pittsburgh and received additional training in genetics and metabolism at Cleveland Clinic and Centers for Inherited Diseases of Metabolism. Dr. Parikh has had the privilege of having Bruce Cohen, Charles Hoppel and Marvin Natowicz serve as his teachers during that time. He joined the Cleveland Clinic in 2004. Since 2007, Dr. Parikh has been selected as one of "America's Best Doctors." He serves as Scientific & Medical Advisor to the United Mitochondrial Disease Foundation, Cyclic Vomiting Syndrome Association and the International Foundation for CDKL5 Research. He is the Past President of the Mitochondrial Medicine Society. He is an invited faculty member of the North American Metabolic Academy. He was on the scientific planning committee of the Child Neurology Society and is an ad hoc reviewer for the Journal of Child Neurology, Journal of Inherited Metabolic Disease and Molecular Genetics & Metabolism.

Learn about current treatment options. About the Speaker Dr. Anselm is a member of MitoAction's medical advisory committee and practices in Child Neurology at Children's Hospital Boston. Her research is focused on clinical presentation of children with mitochondrial disorders and their response to therapy with different medications and vitamins/ supplements. Dr. Anselm is currently participating in several clinical research studies. She is a co-investigator in a study using Dichloroacetate (DCA) to treat children with lactic academia. She sees children enrolled in the protocol when they are admitted to CH for DCA initiation and follows them in the Mitochondrial Program while they are being maintained on the DCA. Dr. Anselm also is Principal Investigator in a study entitled "Indirect calorimetry and nutritional assessment in patients with mitochondrial disorders." Children enrolled in this study undergo evaluation of their resting energy expenditure by indirect calorimetry and nutritional assessment. They also undergo metabolic evaluation by measurement of the levels of micronutrients/vitamins in their blood. Dr. Anselm also is involved in a multicenter study of patients with Angelman syndrome.

The new season of Brain Talks focuses on Brain in the Life Course, kicking off with a focus on pediatric neurology. We are joined by guest Dr David Gómez-Andrés, a specialist in Child Neurology at the University Hospital of Vall d'Hebron in Barcelona and part of the European Paediatric Neurology Society (EPNS), a society for physicians with a research or clinical interest in Paediatric Neurology.Dr Gómez-Andrés was awarded the 2021 EPNS Research Prize by the Neuromuscular Working Group for his work on ‘Pattern Recognition Muscle MRI in Early Onset Muscle Disorders: From Previous Works to Future Plans'. David reported: ‘My plan is to use the award to continue the project of machine learning and data representation in muscle imaging. Probably, we will join this to other sources for hiring a young child neurologist to help us in this project and other ones we have ongoing.'We also welcomed Professor Thomas Sejersen, a senior consultant and lecturer at Karolinska University Hospital in Stockholm and a Board Member of the EPNS, as a co-discussant.Discover more on https://www.epns.info/ and https://www.braininnovationdays.eu

Join MitoAction and Dr. Richard Frye to discuss the distinction between primary and secondary mitochondrial diagnosis. Some talking points will include: Primary mitochondrial disease (PMD) is ideally diagnosed by a known or indisputably pathogenic mitochondrial or nuclear DNA mutation. Secondary mitochondrial dysfunction (SMD) can be caused by genes encoding either function nor production of the oxphos proteins and accompanies many heriditary non-mitochondrial diseases. Secondary mitochondrial dysfunction (SMD) can also be caused by enviornmental factors. In the absence of the ability to diagnose a primary mitochondrial disease (PMD), mitochondrial dysfunction can be effectively treated with standard treatments for PMD. When the etiology of mitochondrial dysfunction is unknown, re-evaluation for genetic and other causes should be revisited on a regular basis. About The Speaker: Dr. Richard Frye is a pediatric neurologist and Chief of the Division of Neurodevelopmental Disorders at Phoenix Children's Hospital. He received his MD/PhD from Georgetown University in 1998. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University. He holds board certifications in Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr. Frye is a national leader in autism research. He has authored over 100 peer-reviewed publications and book chapters, and serves on several editorial boards of scientific and medical journals.

Join us for an informative discussion with Dr. Richard Frye, Director of Autism Research and Director of the Autism Multispecialty Clinic at Arkansas Children's Hospital Research Institute. There is increasing evidence that mitochondrial dysfunction is associated with autism spectrum disorder. Learn more about the latest research investigating the causes of this relationship, including the role of oxidative stress for these children. Topics include: The evidence for mitochondrial disease and dysfunction in autism spectrum disorder The importance of the oxidative stress in autism spectrum disorder and its impact on mitochondrial function The evidence for a subset of children with autism with acquired mitochondria dysfunction as a result of high levels of oxidative stress About The Speaker Dr. Richard Frye is the Director of Autism Research at Arkansas Children's Hospital Research Institute, Director of the Autism Multispecialty Clinic at Arkansas Children's Hospital and Associate Professor in Pediatrics at the University of Arkansas for Medical Sciences. He received his MD/PhD from Georgetown University in 1998. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University. He holds board certifications in Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr. Frye is a national leader in autism research. He has authored over 100 peer-reviewed publications and book chapters, and serves on several editorial boards of prestigious scientific and medical journals. Over the past several years he has completed several clinical studies on children with autism spectrum disorder (ASD), including studies focusing on defining the clinical, behavioral, cognitive, genetic and metabolic characteristics of children with ASD and mitochondrial disease and several clinical trials demonstrating the efficacy of safe and novel treatments that address underlying physiological abnormalities in children with ASD, including open-labels on tetrahydrobiopterin, cobalamin and folinic acid and a recent double-blind placebo controlled trial on folinic acid. Future research efforts are focused on defining physiological endophenotypes of children with ASD and developing targeted treatments.

This Episode Covers the Following Topics:Common causes of headaches in kidsHeadache triggersMigraines (what they are, how common, non-headache migraines & more)Tension headachesPrimary headachesSevere headachesVertigoDizziness and lightheadedness Headache FrequencyWhat to expect during a neuro exam and observationHeadache diaries and how tracking helpsVision changesPrevention, evidence-based treatments , medications & vitaminsCognitive behavior therapyStress management and meditationSleep, diet & exerciseApps Recommended in this episode:Migraine BuddyCalmHeadspaceInsight TimerABOUT DR. PAIGE KALIKA:Dr. Paige Kalika is an Assistant Professor of Clinical Neurology and Pediatrics.  She was born in Brooklyn, NY, and graduated from Cornell University in 2000.  She earned her medical degree at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (now Rowan-SOM) in 2004.  She completed her residency in Pediatrics at Jersey Shore University Medical Center in 2007 and her fellowship in Child Neurology at SUNY Downstate in Brooklyn, NY in 2010.  She is board certified in Neurology with special qualification in Child Neurology and is pursuing certification in headache medicine.Dr. Kalika joined the University of Miami Department of Neurology in 2011.  While she practices general child neurology, she has a particular interest in pediatric headache and migraine.  She is the director of the pediatric headache clinic at UHealth and at Jackson Memorial Hospital, where she does Botox treatments for chronic migraines.  Her research interests include treatment and prevention of acute migraine in pediatric populations.  She also has an interest in pediatric neurogenetics and sees patients in tandem with Genetics at UHealth at Weston.When not seeing patients, Dr. Kalika enjoys reading, baking, and spending time with her husband and two children.  She is slowly amassing an impressive collection of geeky dresses with pockets.  She is a fan of Florida winters, but not Florida summers.

Dr. Katherine Fu discusses the emerging subspecialty of sleep medicine in child neurology.

BGCF is back with more stories of good from local nonprofits on the DoGood Radio Hour! We are featuring nonprofits participating in the 2021 GoodGiving Challenge! This week highlights these nonprofits: The Lexington Theatre Company, Child Neurology Foundation, Kentucky Center for Grieving Children & Families This is a diverse episode with stories that will compel you to see the good happening in our community -- the passion is tangible!

In this weeks episode, Dr Jessica Hochman interviews Dr. Amy Gelfand about children and melatonin.  Many over-the-counter products with melatonin are being marketed as a sleep aid for children, but what do we know about these products? Are they safe for children? Does melatonin help children sleep? Does it help treat pediatric headaches? Are there side effects?  Is it possible for kids to get dependent on these products? We discuss all of this and more!Dr Gelfand is an accomplished pediatric neurologist and headache specialist, and she has researched melatonin and children--exploring melatonin as a means to prevent pediatric headaches (see her publication links below).  Dr. Gelfand attended Harvard Medical School, and completed her Pediatric Residency and Child Neurology training at UCSF.  She is a board certified Child Neurologist and is currently the Director of Pediatric Headache at UCSF.  

In this weeks episode, Dr Jessica Hochman interviews Dr. Amy Gelfand, accomplished pediatric neurologist and headache specialist about pediatric headaches. We review the most common pediatric headaches: tension headaches, migraine headaches and post traumatic headaches. We discuss how to prevent headaches and how to treat headaches. We also review myths about migraines (like does eating chocolate really trigger a migraines?!) and when to see a doctor. We review warning signs for headache emergencies. If you or someone you know suffers from migraines/headaches, this is a discussion you'll especially enjoy. Dr. Gelfand attended Harvard Medical School, and completed her Pediatric Residency and Child Neurology training at UCSF.  She is a board certified Child Neurologist and is currently the Director of Pediatric Headache at UCSF.  

Everything you always wanted to know, but were afraid to ask about the residency application process from a Child Neurology Program Director (Dr. Rana Said). Completing Residency Applications and doing interviews can be full of unexpected twists and turns. Short and helpful tips while you're taking a study break. Acid Trumpet Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/

Everything you always wanted to know, but were afraid to ask about the residency application process from a child neurology resident. Short and helpful tips while you're taking a study break. Acid Trumpet Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/

Our Summer 2021 Series features the rebroadcast of some of our most listened-to episodes from the last 4 seasons of Charting Pediatrics. Do you have a guest or topic suggestion for Season 5? Let us know, chartingpediatrics@childrenscolorado.org In this episode we discuss seizures and spells, and the diagnosis and management of events that worry us. This episode was recorded at the 2019 American Academy of Pediatrics NCE in New Orleans with Mered Parnes, MD and Shavonee Massey, MD, MSCE. Dr. Massey is is a pediatric neurologist in the Division of Neurology at Children's Hospital of Philadelphia, specializing in the care of children with epilepsy and a Clinical Instructor in Pediatrics and Neurology. Dr. Parnes is the Director of the Pediatric Movement of Disorders Clinic and an Assistant Professor of Child Neurology at Texas Children's Hospital and Baylor College of Medicine. Do you have thoughts about today's episode or suggestions for a future topic? Write to us, chartingpediatrics@childrenscolorado.org 

Dr. Karkare is the director of the Pediatric Epilepsy Center at Cohen Children's Medical Center, designated as a level 4 center by the NAEC (National Association of Epilepsy Centers). She is board certified in Epilepsy, Child Neurology and Pediatrics. She completed her training from Children's Hospital of Michigan, University of Michigan and New York Presbyterian Weill Cornell Medical Center. Before joining Northwell, Dr. Karkare was the director of pediatric epilepsy surgery program at Kosair Children's Hospital in Louisville, KY where she successfully established a pediatric surgical program and streamlined complex diagnostic testing that was previously not available in the region. She served on the professional advisory committee of Epilepsy Foundation of Kentuckiana and continues to serve on the advisory board of EPICLI (exceptional partners in care Long Island). Dr. Karkare is the principal co-investigator on HEP-3 ( Human Epilepsy Project-3) trial. She has authored book chapters and has multiple publications and presentations pertaining to pediatric epilepsy. As an assistant professor at Hofstra University Medical School and the program director for Child Neurology residency, Dr. Karkare takes avid interest in teaching and training future child neurologists. Join us Thursday nights at 8 PM EST on Instagram live @jowma_org for our latest podcast discussions!!

Dr. Karkare is the director of the Pediatric Epilepsy Center at Cohen Children's Medical Center, designated as a level 4 center by the NAEC (National Association of Epilepsy Centers). She is board certified in Epilepsy, Child Neurology and Pediatrics. She completed her training from Children's Hospital of Michigan, University of Michigan and New York Presbyterian Weill Cornell Medical Center. Before joining Northwell, Dr. Karkare was the director of pediatric epilepsy surgery program at Kosair Children's Hospital in Louisville, KY where she successfully established a pediatric surgical program and streamlined complex diagnostic testing that was previously not available in the region. She served on the professional advisory committee of Epilepsy Foundation of Kentuckiana and continues to serve on the advisory board of EPICLI (exceptional partners in care Long Island). Dr. Karkare is the principal co-investigator on HEP-3 ( Human Epilepsy Project-3) trial. She has authored book chapters and has multiple publications and presentations pertaining to pediatric epilepsy. As an assistant professor at Hofstra University Medical School and the program director for Child Neurology residency, Dr. Karkare takes avid interest in teaching and training future child neurologists. Join us Thursday nights at 8 PM EST on Instagram live @jowma_org for our latest podcast discussions!! This podcast is powered by JewishPodcasts.org. Start your own podcast today and share your content with the world. Click jewishpodcasts.fm/signup to get started.

Everything you always wanted to know, but were afraid to ask about the residency application process from a Child Neurology Program Director (Dr. Miya Bernson-Leung). Completing Residency Applications and doing interviews can be full of unexpected twists and turns. Short and helpful tips while you're taking a study break. Acid Trumpet Kevin MacLeod (incompetech.com) Licensed under Creative Commons: By Attribution 3.0 http://creativecommons.org/licenses/by/3.0/

Jennifer Bain, MD, PhD, is an assistant professor of neurology at CUIMC, in the Division of Child Neurology. Dr. Bain completed her MD and PhD at Rutgers—New Jersey Medical School and child neurology residency at Columbia University. She sees both inpatient and outpatient pediatric neurology patients, with special interest in behavioral neurology caring for children with developmental delay, autism spectrum disorder, ADHD, genetic disorders. She works closely with families to provide reasonable, scientifically sound and ethically safe treatments for children with these concerns. Join us Thursday nights at 8 PM EST on Instagram live @jowma_org for our latest podcast discussions!! This podcast is powered by JewishPodcasts.org. Start your own podcast today and share your content with the world. Click jewishpodcasts.fm/signup to get started.

Dr. Dallara-Marsh is a neurologist who specializes in working with children. She attended an accelerated BS/MD program, completing undergraduate studies at Sophie Davis School of Biomedical Education and then a medical degree at SUNY Health Science Center in Brooklyn. After those 7 years, she trained in pediatrics at Westchester Medical Center. To further her expertise within the field, Dr. Dallara-Marsh completed fellowships in Neurology with Special Qualification in Child Neurology and Epilepsy at New York Presbyterian Hospital-Columbia. Some of Dr. Dallara-Marsh's interests include child neurology, epilepsy, and palliative care. She currently works in a private-practice setting in New Jersey. When she is not at work, Dr. Dallara-Marsh enjoys mentoring pre-meds and also spending time with her young children. Take the quiz here

Dr. Amy Goldstein provides an update on the Mitochondrial Medicine Society. Areas of discussion include: Transplantation in Mito patients Stroke protocol for MELAS Standards of care for Mito patients Centers of Excellence and the need for community involvement/input About the Speaker Dr. Amy Goldstein, a member of the Board of Trustees of UMDF, is on faculty at Children’s Hospital of Pittsburgh of UPMC in the Division of Pediatric Neurology. She is board certified in pediatrics, neurology, and psychiatry with Special Qualifications in Child Neurology. She is currently an Assistant Professor at the University of Pittsburgh School of Medicine. She began a multidisciplinary Mitochondrial Disease clinic in 2007 and is now the Director of Neurogenetics & Metabolism and the site Principle Investigator for NAMDC (the North American Mitochondrial Disease Consortium). She is also President of the Mitochondrial Medicine Society. Her clinical research interests include improving fatigue and exercise intolerance as well as developing common patient-centered outcome measures for clinical trials. To view the accompanying slides, click here.

Podcast Transcript coming soon: Can ADHD symptoms be treated by stimulating the brain while someone sleeps? The Monarch external Trigeminal Nerve Stimulation (eTNS) System, a new device recently approved by the US Food and Drug Administration offers that possibility. Some parents on social media say they're ready to sign up their child for testing. Is it too soon for people managing ADHD to jump ship from their current treatment regimen?  We will hear from Dr. Max Wiznitzer, an associate professor of pediatrics, neurology, and international health at Case Western Reserve University. He serves on CHADD's board of directors and the editorial advisory board for Attention magazine, as well as the editorial boards of Lancet Neurology, and the Journal of Child Neurology. Dr. Wiznitzer lectures nationally and internationally about various neurodevelopmental disabilities.